InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Saturday, 12/09/2017 10:51:35 PM

Saturday, December 09, 2017 10:51:35 PM

Post# of 37495
OMHE_Projected_Revenues_FY2018=$8_to_$10Million_&_FY2019=$15_to_$17Million_More_Rev_Add_MMJ_Products_are_in_the_pipeline

June-13-2017: Omni Health, Inc. Announces Roll Out of Anti-Aging Product Line & Revenue Add to $10Million Total - Read Here

Dec-05-2017: MMJ Medicine Development, FDA Approval Plan & $7 Million Revenue Add News - Read Here


Simultaneous to the FDA application for this new drug, the Company will commence by manufacturing OTC analgesic creams and ointments containing CBD with rapid absorption and optimal bioavailability profiles. Given the potency of these analgesics, they will be marketed and distributed exclusively to doctors’ offices, clinics, and hospitals to ensure appropriate patient support and product usage. As per the current schedule, it’s anticipated they this product will be introduced to the North American market during Q3 2018. Based on current market trends and competitor analysis, Omni Health projects generating a recurring annual revenue exceeding $7 Million.




OMHE PPS is heading to $1

Made Thousands into Millions..Now in Tens of Millions